We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04459715
Brief Title: A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX)

First Submitted : June 30, 2020
First Submitted that Met QC Criteria : July 3, 2020
First Posted : July 7, 2020

Last Update Submitted that Met QC Criteria : August 22, 2022
Last Update Posted : August 25, 2022